tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Alpha Tau Medical Ltd

DRTS
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
10.360USD
-0.050-0.48%
์ข…๊ฐ€ย 05/15, 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
911.78M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM
๎™

์ž์„ธํ•œ ๋‚ด์šฉ์€ Alpha Tau Medical Ltd ํšŒ์‚ฌ

Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.

Alpha Tau Medical Ltd ์ •๋ณด

๎™Œ
์ข…๋ชฉ ์ฝ”๋“œ DRTS
ํšŒ์‚ฌ ์ด๋ฆ„Alpha Tau Medical Ltd
์ƒ์žฅ์ผMar 08, 2022
CEOSofer (Uzi)
์ง์› ์ˆ˜125
์œ ํ˜•Ordinary Share
ํšŒ๊ณ„ ์—ฐ๋„ ์ข…๋ฃŒMar 08
์ฃผ์†ŒKiryat Hamada 5
๋„์‹œJERUSALEM
์ฆ๊ถŒ ๊ฑฐ๋ž˜์†ŒNASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐ€Israel
์šฐํŽธ ๋ฒˆํ˜ธ9777605
์ „ํ™”97235774115
์›น์‚ฌ์ดํŠธhttps://www.alphatau.com/
์ข…๋ชฉ ์ฝ”๋“œ DRTS
์ƒ์žฅ์ผMar 08, 2022
CEOSofer (Uzi)

Alpha Tau Medical Ltd์˜ ํšŒ์‚ฌ ์ž„์›์ง„

๎™Œ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. Uzi Sofer
Mr. Uzi Sofer
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
11.52M
--
Mr. Michael Avruch
Mr. Michael Avruch
Independent Director
Independent Director
1.52M
-2.26%
Prof. Yona Keisari
Prof. Yona Keisari
Chief Scientific Officer
Chief Scientific Officer
503.49K
-0.16%
Mr. Amnon Gat
Mr. Amnon Gat
Chief Operations Officer
Chief Operations Officer
68.47K
--
Mr. Raphi Levy
Mr. Raphi Levy
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Ronen Segal
Mr. Ronen Segal
Chief Technology Officer
Chief Technology Officer
--
--
Prof. Itzhak Kelson
Prof. Itzhak Kelson
Chief Physics Officer
Chief Physics Officer
--
--
Dr. Robert Den, M.D.
Dr. Robert Den, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Ruth Alon
Ms. Ruth Alon
Director
Director
--
--
Dr. S. Morry Blumenfeld, Ph.D.
Dr. S. Morry Blumenfeld, Ph.D.
Independent Director
Independent Director
--
--
๋” ๋ณด๊ธฐ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. Uzi Sofer
Mr. Uzi Sofer
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
11.52M
--
Mr. Michael Avruch
Mr. Michael Avruch
Independent Director
Independent Director
1.52M
-2.26%
Prof. Yona Keisari
Prof. Yona Keisari
Chief Scientific Officer
Chief Scientific Officer
503.49K
-0.16%
Mr. Amnon Gat
Mr. Amnon Gat
Chief Operations Officer
Chief Operations Officer
68.47K
--
Mr. Raphi Levy
Mr. Raphi Levy
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Ronen Segal
Mr. Ronen Segal
Chief Technology Officer
Chief Technology Officer
--
--

์ˆ˜์ต ๋ถ„์„

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.
์‚ฌ์—…๋ณ„
์ง€์—ญ๋ณ„
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ๋ณด์œ  ํ†ต๊ณ„

๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Thu, May 14
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Thu, May 14
์ฃผ์ฃผ
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
Oramed Pharmaceuticals Inc
16.44%
Sofer (Uzi)
13.08%
Avruch (Michael)
1.72%
Hightower Advisors, LLC
0.99%
Keisari (Yona)
0.57%
๊ธฐํƒ€
67.18%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
Oramed Pharmaceuticals Inc
16.44%
Sofer (Uzi)
13.08%
Avruch (Michael)
1.72%
Hightower Advisors, LLC
0.99%
Keisari (Yona)
0.57%
๊ธฐํƒ€
67.18%
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
๋น„์œจ
Corporation
16.44%
Individual Investor
15.61%
Investment Advisor
2.38%
Investment Advisor/Hedge Fund
0.61%
Bank and Trust
0.27%
Hedge Fund
0.12%
Research Firm
0.08%
๊ธฐํƒ€
64.48%

๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ 

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Wed, Apr 1
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Wed, Apr 1
๋ณด๊ณ  ๊ธฐ๊ฐ„
๊ธฐ๊ด€ ์ˆ˜
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
2026Q1
58
3.34M
3.80%
+118.69K
2025Q4
47
2.15M
2.50%
--
2025Q3
54
2.18M
2.66%
+245.80K
2025Q2
48
1.93M
2.17%
+414.57K
2025Q1
48
1.52M
2.85%
-495.42K
2024Q4
46
1.33M
2.80%
+27.93K
2024Q3
50
1.30M
4.99%
-29.19K
2024Q2
53
1.33M
5.76%
-530.87K
2024Q1
56
1.86M
5.76%
-2.16M
2023Q4
128
1.91M
37.70%
+832.42K
๋” ๋ณด๊ธฐ

์ฃผ์ฃผ ํ™œ๋™

๎™Œ
์ด๋ฆ„
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
Chg %
๋‚ ์งœ
Oramed Pharmaceuticals Inc
14.47M
16.44%
+359.21K
+2.55%
Mar 01, 2026
Sofer (Uzi)
11.52M
13.08%
--
--
Mar 01, 2026
Avruch (Michael)
1.52M
1.72%
-34.28K
-2.21%
Mar 01, 2026
Hightower Advisors, LLC
686.55K
0.78%
--
--
Dec 31, 2025
Keisari (Yona)
503.49K
0.57%
-781.00
-0.15%
Mar 01, 2026
Apella Wealth
382.28K
0.43%
+382.28K
--
Dec 31, 2025
ARK Investment Management LLC
292.13K
0.33%
--
--
Feb 28, 2026
Levin Capital Strategies, L.P.
182.23K
0.21%
-22.48K
-10.98%
Dec 31, 2025
Kovitz Investment Group Partners, LLC
157.86K
0.18%
-45.37K
-22.33%
Dec 31, 2025
๋” ๋ณด๊ธฐ

๊ด€๋ จ ETF

๎™Œ
์ด๋ฆ„
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ

์ฃผ์‹ ๋ฐฐ๋‹น๊ธˆ

๎™Œ
์ง€๋‚œ 5๋…„ ๋™์•ˆ ์ด 0.00 USD์˜ ๋ฐฐ๋‹น๊ธˆ์ด ๋ถ„๋ฐฐ๋˜์—ˆ์Šต๋‹ˆ๋‹ค.
๋‚ ์งœ
๋ฐฐ๋‹น๊ธˆ
๊ธฐ์ค€์ผ
์ง€๊ธ‰์ผ
๋ฐฐ๋‹น๋ฝ์ผ
๋ฐ์ดํ„ฐ ์—†์Œ

์ฃผ์‹ ๋ถ„ํ• 

๎™Œ
๋‚ ์งœ
๋ฐฐ๋‹น๋ฝ์ผ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ
๋‚ ์งœ
๋ฐฐ๋‹น๋ฝ์ผ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ
KeyAI
๎™